Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?

References

• Ronsmans C, Graham WJ. Maternal mortality: who, when, where and why. Lancet. 2006; 368: 1189–1200.
   PubMed Web of Science ®Google Scholar
• Gülmezoglu AM, Villar J, Ngoc NTN, Piaggio G, Carroli G, Adetoro L, et al.. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001; 358: 689–95.
   PubMed Web of Science ®Google Scholar
• Langenbach C. Misoprostol in preventing postpartum hemorrhage: a meta-analysis. Int J Gynaecol Obstet. 2006; 92: 10–18.
   PubMed Web of Science ®Google Scholar
• Miller S, Lester F, Hensleigh P. Prevention and treatment of postpartum haemorrhage: new advances for low-resource settings. J Midwifery Women Health. 2004; 49: 283–92.
   PubMed Web of Science ®Google Scholar
• Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med. 2001; 344: 38–47.
   PubMed Web of Science ®Google Scholar
• International Confederation of Midwives and International Federation of Gynaecology and Obstetrics. Prevention and treatment of post-partum haemorrhage: new advances for low resource settings. Int J Gynecol Obstet. 2007; 97: 160–3.
   Web of Science ®Google Scholar
• World Health Organisation. WHO recommendations for the prevention of postpartum haemorrhage. Geneva: Author. 2007, pp. 14–15.
   Google Scholar
• Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al.. Oral misoprostol in preventing postpartum haemorrhage in resource poor communities: a randomized control trial. Lancet. 2006; 368: 1248–53.
   PubMed Web of Science ®Google Scholar
• Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol. 1998; 179: 1043–46.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol. 1998; 105: 971–5.
   PubMedGoogle Scholar
• Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ. 2005; 331: 723.
   PubMed Web of Science ®Google Scholar
• Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynaecol Obstet. 2010; 108: 276–81.
   PubMed Web of Science ®Google Scholar
• Sanghvi H, Wiknjosastro G, Chanpong G, Fishel J, Ahmed S, Zulkarnain M. Prevention of postpartum haemorrhage study, West Java, Indonesia. JHPIEGO, Maternal and Neonatal Health Programme. Baltimore MD, 2004
   Google Scholar
• Rajbhandri S, Pun A, Hodgins S, Rajendra PK. Prevention of postpartum haemorrhage at home birth with use of misoprostol in Banke District, Nepal. Int J Gynaecol Obstet. 2006; 94: S143–S144.
   Web of Science ®Google Scholar
• Prata N, Mbaruku G, Campbell M, Potts M, Vahidinia F. Controlling postpartum haemorrage after home births in Tanzania. Int J Gynecol Obstet. 2005; 90: 51–55.
   PubMed Web of Science ®Google Scholar
• Prata N, Gessessew A, Abraha AK, Holston M, Potts M. Prevention of postpartum haemorrhage: options for home birth in rural Ethiopia. Afr J Reprod Health. 2009; 13: 87–95.
   Google Scholar
• Bangladesh Bureau of Statistics (BBS). Planning commission, Ministry of Planning. DhakaBangladesh: Author. 2004.
   Google Scholar
• Bangladesh Demographic and Health Survey. Dhaka, Bangladesh and Calverton, Maryland, USA: National Institute of Population Research and Training (NIPORT), Mitra and Associates, and Macro International Inc; 2007.
   Google Scholar
• Bangladesh Maternal Mortality Survey. Final report. Bangladesh maternal health services and maternal mortality survey 2001. Dhaka: National Institute of Population Research and Training (NIPORT) and Measure DHS + ORC Macro. 2003.
   Google Scholar
• Government of People's Republic of Bangladesh and UNDP. Millennium development goals: Bangladesh progress report 2008. General Economics Division, Planning Commission, Government of People's Republic of Bangladesh. , Dhaka: Author. 2008.
   Google Scholar
• Gwatkin D, Rutstein S, Johnson S, Pande R, Wagstaff A. Differences in health, nutrition, and population in Bangladesh 1996/1997, 1999/2000, 2004. WashingtonDC: World Bank, Human Development Network. 2007.
   Google Scholar
• Romnet AK, Weller SC, Batchelder WH. Cultural as consensus: a theory of culture, informant accuracy. Am Anthropol. 1986; 88: 313–38.
   Web of Science ®Google Scholar
• Sibley LM, Hruschka DJ, Kalim N, Khan J, Paul M, Edmonds JK, et al.. Cultural theories of postpartum bleeding Matlab, Bangladesh: implications for community health intervention. J Health Popul Nutr. 2009; 27: 379–90.
   Web of Science ®Google Scholar
• Jadesimi A, Okonofua FE. Tackling the unacceptable: Nigeria approves misoprostol for PPH. J Fam Plann Reprod Health Care. 2006; 32: 213–41.
   PubMedGoogle Scholar
• Walley RL, Wilson JB, Crane JM, Matthews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG. 2000; 107: 1111–15.
   PubMed Web of Science ®Google Scholar
• Zachariah ES, Naidu M, Seshadri L. Oral misoprostol in the third stage of labor. Int J Gynaecol Obstet. 2006; 92: 23–26.
   PubMed Web of Science ®Google Scholar
• El-Refaey H, Nooh R, O'Brien P, Abdalla M, Geary M, Walder J, et al.. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. BJOG. 2000; 107: 1104–10.
   PubMed Web of Science ®Google Scholar
• Caliskan E, Dilbaz B, Meydanli MM, Ozturk N, Narin MA, Haberal A. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol. 2003; 101: 921–8.
   PubMed Web of Science ®Google Scholar
• Oboro VO, Tabowei TO. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour. J Obstet Gynaecol. 2003; 23: 13–16.
   PubMedGoogle Scholar
• Maughan KL, Heim SW, Galazka SS. Preventing postpartum haemorrhage: managing third stage of labor. Am Fam Physician. 2006; 74: 1015–28.
   Google Scholar
• Selo-Ojeme DO, Okonofua FE. Risk factors for primary postpartum haemorrhage. A case control study. Arch Gynecol Obstet. 1997; 259: 179–87.
   PubMed Web of Science ®Google Scholar
• Afolabi EO, Kuti O, Orji EO, Ogunniyi SO. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour. Singapore Med J. 2010; 51: 207–11.
   PubMed Web of Science ®Google Scholar
• Nisa MU, Zahida, Sadia, Misbah, Nawaz R, Shazia, et al.. Prophylaxis of atonic postpartum hemorrhage with misoprostol in underdeveloped countries. Annals of KEMU. 2009; 15: 185–9.
   Google Scholar
• Hofmeyr GJ, Nikodem VC, de Jager M, Drakely A. Side-effects of oral misoprostol in the third stage of labour – a randomized placebo-controlled trial. S Afr Med J. 2001; 91: 432–5.
   PubMed Web of Science ®Google Scholar
• Lumbiganon P, Villar J, Piaggio G, Gulmezoglu AM, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG. 2002; 109: 1222–6.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Gulmezoglu AM, Novikova N, Linder V, Ferreira A, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ. 2009; 87: 666–77.
   PubMed Web of Science ®Google Scholar